Doxorubicin

specific

40

Centers

0

Active Trials

$130M

Cancer Funding

Top Centers for Doxorubicin(40)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
68.3
2
NCI Comprehensive
Active Research Program
67.4
3
NCI Comprehensive
Active Research Program
66.6
4
NCI Comprehensive
Active Research Program
65.7
5
NCI Comprehensive
Active Research Program
64.8
6
NCI Clinical
Active Research Program
63.9
7
NCI Comprehensive
Active Research Program
63.1
862.2
9
Active Research Program
61.3
10
Active Research Program
60.4
1159.6
12
NCI Comprehensive
Active Research Program
58.7
13
NCI Comprehensive
Active Research Program
57.8
14
Active Research Program
56.9
15
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
56.1
16
NCI Basic_laboratory
Active Research Program
55.2
17
NCI Comprehensive
Active Research Program
54.3
18
NCI Comprehensive
Active Research Program
53.4
1952.6
2051.7
21
NCI Comprehensive
Active Research Program
50.8
22
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
49.9
23
NCI Comprehensive
Active Research Program
49.1
24
NCI Comprehensive
Active Research Program
48.2
25
NCI Comprehensive
Active Research Program
47.3
26
NCI Comprehensive
Active Research Program
46.4
27
NCI Clinical
Active Research Program
45.6
28
Active Research Program
44.7
29
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
43.8
30
NCI Comprehensive
Active Research Program
42.9
31
Active Research Program
42.1
32
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
41.2
33
NCI Comprehensive
Active Research Program
40.3
34
NCI Comprehensive
Active Research Program
39.4
35
WVU Cancer InstituteMorgantown, WV
Active Research Program
38.6
36
NCI Comprehensive
Active Research Program
37.7
37
NCI Comprehensive
Active Research Program
36.8
38
NCI Comprehensive
35.1
3935.1
4035.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →